Problem statement: Answer the MCQ question.
Query: Which compound exhibits a -28.537% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) CN(CC(=O)Nc1cccc(F)c1)C(=O)c1cc(=O)[nH]c2ccccc12
b) Cc1ccc(C(=O)Nc2ccc3c(c2)nc(CCNC(=O)c2ccco2)n3C)cc1
c) Clc1ccc(-c2noc(CN(Cc3ccccn3)CC3CCCO3)n2)cc1
Answer: c. Clc1ccc(-c2noc(CN(Cc3ccccn3)CC3CCCO3)n2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Clc1ccc(-c2noc(CN(Cc3ccccn3)CC3CCCO3)n2)cc1
Clc1ccc(-c2noc(CN(Cc3ccccn3)CC3CCCO3)n2)cc1
N-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-(oxolan-2-yl)-N-(pyridin-2-ylmethyl)methanamine